Global custom synthesis specialist Saltigo GmbH will be raising its prices for the product group 1,2,4 Triazol (CAS 00288-88-0) by 10 % effective September 1, 2010. The reasons for the measure are substantial increases in raw materials and energy costs.

Saltigo is one of the leader in the production and marketing of 1,2,4 Triazol. The intermediate is used, among other things, in the chemical synthesis of active agricultural and pharmaceutical ingredients.

Saltigo GmbH is a leading supplier in the field of custom synthesis. The company of specialty chemicals group LANXESS belongs to the Advanced Intermediates segment, which achieved total sales in 2009 of EUR 1,104 million. Saltigo, headquartered in Langenfeld and with production facilities in Leverkusen and Dormagen, employs around 1,400 staff worldwide. LANXESS Corporation operates a site for Saltigo in Redmond (Washington, United States).